Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 06, 2025 09:30 ET | Source: SNS Insider pvt ltd

Opioid Use Disorder Market Size Projected to Hit USD 9.02 Billion by 2032 - SNS Insider

Austin, United States, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Opioid Use Disorder Market Size & Growth Analysis: According to SNS Insider, The Opioid Use Disorder Market size was valued at USD 3.7...
September 27, 2023 13:25 ET | Source: Transparency Market Research

Addiction Treatment Market Size & Share Worth USD 12 billion by 2030, Garnering 6% CAGR – Exclusive Report by Transparency Market Research

Wilmington, Delaware, United States, Sept. 27, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The addiction treatment market was estimated to have acquired US$ 6.39 billion in 2020. It...
April 25, 2018 20:29 ET | Source: Heroin Detox Clinics

Top Agencies Warn Against the Dangers of Heroin Laced with Fentanyl

SAN DIEGO, April 25, 2018 (GLOBE NEWSWIRE) -- National resource for heroin treatment and information reports on new dangerous trend. Heroin Detox Clinics announces the heroin and Fentanyl...
April 11, 2018 19:24 ET | Source: Heroin Detox Clinics

Opioid Epidemic and Heroin Addiction Explained By Heroindetoxclinics.com

SAN DIEGO, April 11, 2018 (GLOBE NEWSWIRE) -- Heroin Detox Clinics provides access to news story & current updates on drug addiction in America and Heroin. Drug addiction ruins the entire...
February 21, 2018 09:00 ET | Source: AXIM BIOTECHNOLOGIES, INC

CBS News Covers AXIM Biotech’s Patent Filing for Controlled-Release Chewing Gum to Provide Treatment for Opioid Addiction

NEW YORK, Feb. 21, 2018 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTCQB:AXIM), a world leader in cannabinoid research and development, today announced that CBS News...
June 23, 2017 09:00 ET | Source: AXIM Biotechnologies, Inc

AXIM Biotech Files Patent on Controlled Release Chewing Gum to Provide Opioid Addiction Treatment

NEW YORK, June 23, 2017 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc. (AXIM Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced that the company filed with...